Related Experiment Video
Updated: Jan 22, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Updates in systemic sclerosis pathogenesis: Toward new therapeutic opportunities]
K Didier1, A Robbins1, F Antonicelli2
1Service de médecine interne, maladies infectieuses et immunologie clinique, faculté de médecine de Reims, CHU de Reims, 51100 Reims, France; EA 7509 Immuno-régulation et remodelage tissulaire dans le cancer et dans les maladies auto-immunes et inflammatoires, université Reims Champagne Ardenne, 51100 Reims, France.
Abstract:
Systemic sclerosis is a rare connective tissue disease characterized by skin and several internal organ fibrosis, systemic vasculopathy and immune abnormalities. Even if fibroblasts and endothelial cells dysfunction, as well as lymphocytes and other immune cells implication are now well described, the exact origin and chronology of the disease pathogenesis remain unclear. Oxidative stress, influenced by genetic and environmental factors, seems to play a key role. Indeed, it seems to be implicated in the early phases of fibrosis development, vasculopathy and in immune tolerance abnormalities shared by all patients, although disease expression is heterogeneous. To date, no curative treatment is available. Even if immunosuppressive treatment or drugs acting on vascular system are proposed for some patients, overall, treatment efficiency remains modest. Only autologous hematopoietic stem cells transplantation, reserved for patients with severe or rapidly progressive fibrosis, has recently demonstrated efficiency, with lasting regression of fibrosis. Nevertheless, this treatment can expose to important, life-threatening toxicity. In the last decade, new mechanisms implicated in the pathogenesis of systemic sclerosis have been unraveled, bringing new therapeutic opportunities. In this review, we offer to focus on recent insights in the knowledge of systemic sclerosis pathogenesis and its implication in current and future medical care.
Insights
Systemic sclerosis involves fibrosis and immune issues, with oxidative stress a key factor. While treatments are limited, autologous stem cell transplants show promise for severe cases, despite risks.
Area of Science:
- Rheumatology
- Immunology
- Fibrosis Research
Background:
- Systemic sclerosis is a rare connective tissue disease featuring fibrosis, vasculopathy, and immune abnormalities.
- The precise origin and chronological development of systemic sclerosis pathogenesis remain incompletely understood.
- Oxidative stress, influenced by genetic and environmental factors, is implicated in early disease phases.
Purpose of the Study:
- To review recent advancements in understanding systemic sclerosis pathogenesis.
- To explore the implications of new pathogenic insights for current and future medical care.
- To highlight novel therapeutic opportunities arising from a deeper knowledge of the disease.
Main Methods:
- Literature review focusing on recent research in systemic sclerosis.
- Analysis of studies investigating the role of oxidative stress and immune cells.
- Evaluation of current and emerging therapeutic strategies.
Main Results:
- Fibroblast and endothelial cell dysfunction, alongside immune cell involvement, are key features.
- Oxidative stress appears crucial in early fibrosis, vasculopathy, and immune tolerance.
- Autologous hematopoietic stem cell transplantation offers lasting fibrosis regression in severe cases but carries significant toxicity.
Conclusions:
- Recent discoveries have illuminated new mechanisms in systemic sclerosis pathogenesis.
- These insights are paving the way for improved therapeutic strategies.
- Further research into pathogenic pathways is essential for developing effective treatments.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Therapeutic Index
Second Order systems II

